15th Annual NATA Symposium
Scientific Program
Thursday, April 10, 2014
MORNING
8:45-9:00 Welcome Address
Dafydd Thomas, Swansea, Wales, UK
BLOOD TRANSFUSION SERVICES IN 2014
Rainer Moog, Berlin, Germany
Matilde Santos, Lisbon, Portugal
9:00-9:20 Update on the Safety of Blood Products
Lawrence Tim Goodnough, Stanford, CA, USA
9:20-9:40 Informed Consent for Transfusion
Richard Daniel, London, UK
9:40-10:00 Trends in Blood Utilization
Lawrence Tim Goodnough, Stanford, CA, USA
10:00-10:30 Questions and Answers
10:30-11:00 Break
THE SAFETY OF BLOOD AND ALTERNATIVES
Jens Meier, Tübingen, Germany
José Eduardo Torres de Eckenroth Guimarães, Porto, Portugal
11:00-11:20 Age of Blood: Does It Matter?
Jeffrey L. Carson, New Brunswick, NJ, USA
11:20-11:40 The Safety of Intravenous Iron and Erythropoiesis-Stimulating Agents
Iain C. Macdougall, London, UK
11:40-12:00 The Safety of Antifibrinolytics and Recombinant Activated Factor VII
Beverley J. Hunt, London, UK
12:00-12:30 Questions and Answers
WORKSHOP: CELL SALVAGE FOR THE INEXPERIENCED
—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES
Dafydd Thomas, Swansea, Wales, UK
Jonathan H. Waters, Pittsburg, PA, USA
11:00-12:30 (Maximum 30 participants)
WORKSHOP: PERIOPERATIVE AND EMERGENCY MANAGEMENT OF ORAL ANTICOAGULANTS
Charles-Marc Samama, Paris, France
Marcel Levi, Amsterdam, The Netherlands
11:00-12:30 (Maximum 30 participants)
LUNCHTIME INDUSTRY-SPONSORED SATELLITE SYMPOSIUM
Importance of Fat Elimination in Intraoperative Blood Salvage
12:45-13:15 Positive Effects of Intraoperative Blood Salvage and Fat Elimination
during Cardiac Surgery
George N. Djaiani, Toronto, ON, Canada
13:15-13:45 Continuous Autotransfusion Allows for Fat Elimination
during Orthopedic Surgery
Michael Booke, Bad Soden am Taunus, Germany
13:45-14:15 Questions and Answers
Thursday, April 10, 2014
AFTERNOON
CELL SALVAGE: WHEN AND HOW?
Manuel Muñoz, Málaga, Spain
Lucindo Ormonde, Lisbon, Portugal
14:30-14:50 Basic Principles and Safety of Cell Salvage
Dafydd Thomas, Swansea, Wales, UK
14:50-15:10 Cell Salvage in Cancer Surgery
Jonathan H. Waters, Pittsburgh, PA, USA
15:10-15:30 Washing of Banked Red Blood Cells with Cell Salvage Devices
Ernil Hansen, Regensburg, Germany
15:30-16:00 Questions and Answers
WORKSHOP: PATIENT BLOOD MANAGEMENT
—THE BASICS
Elvira Bisbe, Barcelona, Spain
Oliver Habler, Frankfurt, Germany
14:30-16:00 (Maximum 30 participants)
WORKSHOP: MANAGEMENT OF MASSIVE BLEEDING
—MEET THE EXPERTS
Sibylle A. Kozek-Langenecker, Vienna, Austria
Rolf Rossaint, Aachen, Germany
14:30-16:00 (Maximum 30 participants)
16:00-16:30 Break
BEST POSTERS’ PRESENTATION
Jean-François Hardy, Montreal, QC, Canada
Elvira Bisbe, Barcelona, Spain
16:30-16:45 Factors Influencing the Delay in Traumatic Coagulopathy Occurrence Following Traumatic Brain Injury
Frédéric Dallaire, Montreal, QC, Canada
16:45-17:00 Preoperative Anemia and Its Impact on Clinical Outcomes in Patients Undergoing Non-Cardiac Surgery: An Audit at Centro Hospitalar Porto
Diogo Sobreira Fernandes, Porto, Portugal
17:00-17:15 Cell Salvage in Hip and Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials
Cynthia So-Osman, Leiden, The Netherlands
17:15-17:30 Tight Control of Coagulopathy Decreases Overall Transfusion and Results in Improved Patient Outcomes
Maria Armstrong, London, UK
17:45-18:30 NATA General Assembly
Friday, April 11, 2014
MORNING
BREAKING NEWS
Dafydd Thomas, Swansea, Wales, UK
Hans Gombotz, Linz, Austria
9:00-9:20 Transfusion Thresholds for Patients with Coronary Artery Disease
Jeffrey L. Carson, New Brunswick, NJ, USA
9:20-9:40 Targeted Action for Curing Trauma Induced Coagulopathy (TACTIC)
—A 5-year Research Program to Investigate Abnormal Bleeding in Trauma Patients
Pär I. Johansson, Copenhagen, Denmark
9:40-10:00 Perioperative Administration of Intravenous Iron Isomaltoside 1000 (Monofer®) in Non-anemic Patients Undergoing Cardiac Surgery
Daniel Steinbrüchel, Copenhagen, Denmark
10:00-10:30 Questions and Answers
10:30-11:00 Break
THE CHALLENGES POSED BY NEW ORAL ANTICOAGULANTS
Charles-Marc Samama, Paris, France
Marcel Levi, Amsterdam, The Netherlands
11:00-11:20 Can We Monitor New Oral Anticoagulants?
Michael Spannagl, Munich, Germany
11:20-11:40 The Perioperative Management of New Oral Anticoagulants in Elective Surgery
Charles-Marc Samama, Paris, France
11:40-12:00 Urgent Reversal of New Oral Anticoagulants
Marcel Levi, Amsterdam, The Netherlands
12:00-12:30 Questions and Answers
WORKSHOP: CELL SALVAGE FOR THE INEXPERIENCED
—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES
Dafydd Thomas, Swansea, Wales, UK
Jonathan H. Waters, Pittsburgh, PA, USA
11:00-12:30 (Maximum 30 participants)
WORKSHOP: MANAGEMENT OF MASSIVE BLEEDING
—MEET THE EXPERTS
Sibylle A. Kozek-Langenecker, Vienna, Austria
Rolf Rossaint, Aachen, Germany
11:00-12:30 (Maximum 30 participants)
LUNCHTIME INDUSTRY-SPONSORED LECTURES
12:45-13:05 Identifying Cardiac Surgery Patients at Risk of Major Transfusion: A Review of 1349 Patients Operated at the Montreal University Health Center
Jean-François Hardy, Montreal, QC, Canada
13:05-13:15 Questions and Answers
13:15-13:35 When Is Aprotinin an Essential Medication to Reduce Bleeding in Cardiac Surgery?
Jan van der Linden, Stockholm, Sweden
13:35-13:45 Questions and Answers
LUNCHTIME INDUSTRY-SPONSORED LECTURE
13:45-14:05 A New Approach to Transfusion Triggers in Elective Surgery
Giambattista Bertani, Milan, Italy
14:05-14:15 Questions and Answers
Friday, April 11, 2014
AFTERNOON
UNDERSTANDING AND MONITORING COAGULOPATHY IN CLINICAL PRACTICE
Pär I. Johansson, Copenhagen, Denmark
Luis Manuel Cunha Ribeiro, Porto, Portugal
14:30-14:50 Understanding and Monitoring Coagulopathy in Elective Surgery
Sibylle A. Kozek-Langenecker, Vienna, Austria
14:50-15:10 Understanding and Monitoring Coagulopathy in Trauma
Rolf Rossaint, Aachen, Germany
15:10-15:30 Understanding and Monitoring Coagulopathy in Obstetrics
Beverley J. Hunt, London, UK
15:30-16:00 Questions and Answers
WORKSHOP: PATIENT BLOOD MANAGEMENT
—THE BASICS
Hans Gombotz, Linz, Austria
Oliver Habler, Frankfurt, Germany
14:30-16:00 (Maximum 30 participants)
WORKSHOP: PERIOPERATIVE AND EMERGENCY MANAGEMENT OF ORAL ANTICOAGULANTS
Charles-Marc Samama, Paris, France
David Faraoni, Brussels, Belgium
14:30-16:00 (Maximum 30 participants)
16:00-16:30 Break
PRO/CON DEBATE:
SHOULD HYDROXYETHYL STARCHES BE ABANDONED?
Oliver Habler, Frankfurt, Germany
Ricardo Matos, Lisbon, Portugal
16:30-16:50 Yes, Hydroxyethyl Starches Should Be Abandoned
Nicolai Haase, Copenhagen, Denmark
16:50-17:10 No, Hydroxyethyl Starches Should Not Be Abandoned
Philippe Van der Linden, Brussels, Belgium
17:10-17:30 Discussion
17:30 Concluding Comments
Dafydd Thomas, Swansea, Wales, UK